BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30367331)

  • 1. Type 2 diabetes as a predictor of survival among breast cancer patients: the multiethnic cohort.
    Maskarinec G; Shvetsov YB; Conroy SM; Haiman CA; Setiawan VW; Le Marchand L
    Breast Cancer Res Treat; 2019 Feb; 173(3):637-645. PubMed ID: 30367331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 2 diabetes and colorectal cancer survival: The multiethnic cohort.
    Amshoff Y; Maskarinec G; Shvetsov YB; Raquinio PH; Grandinetti A; Setiawan VW; Haiman CA; Le Marchand L
    Int J Cancer; 2018 Jul; 143(2):263-268. PubMed ID: 29441528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status.
    Lee KN; Torres MA; Troeschel AN; He J; Gogineni K; McCullough LE
    PLoS One; 2020; 15(5):e0232581. PubMed ID: 32369516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol lowering drug use and breast cancer survival: the Multiethnic Cohort Study.
    Moksud N; Loo LWM; Yang J; Huang CY; Haiman CA; Le Marchand L; Wilkens LR; Cheng I
    Breast Cancer Res Treat; 2021 Nov; 190(1):165-173. PubMed ID: 34460030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of type 2 diabetes genetic variants with breast cancer survival among Chinese women.
    Bao PP; Zhao ZG; Gao YT; Zheng Y; Zhang B; Cai H; Zheng W; Shu XO; Lu W
    PLoS One; 2015; 10(2):e0117419. PubMed ID: 25679392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 2 diabetes and obesity in midlife and breast cancer risk in the Reykjavik cohort.
    Maskarinec G; Haraldsdóttir Á; Einarsdóttir K; Aspelund T; Tryggvadóttir L; Harris TB; Gudnason V; Torfadóttir JE
    Cancer Causes Control; 2019 Oct; 30(10):1057-1065. PubMed ID: 31401707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethnic differences in the relationships between diabetes, early age adiposity and mortality among breast cancer survivors: the Breast Cancer Health Disparities Study.
    Connor AE; Visvanathan K; Baumgartner KB; Baumgartner RN; Boone SD; Hines LM; Wolff RK; John EM; Slattery ML
    Breast Cancer Res Treat; 2016 May; 157(1):167-78. PubMed ID: 27116186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes and other comorbidities in breast cancer survival by race/ethnicity: the California Breast Cancer Survivorship Consortium (CBCSC).
    Wu AH; Kurian AW; Kwan ML; John EM; Lu Y; Keegan TH; Gomez SL; Cheng I; Shariff-Marco S; Caan BJ; Lee VS; Sullivan-Halley J; Tseng CC; Bernstein L; Sposto R; Vigen C
    Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):361-8. PubMed ID: 25425578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking and Risk of Breast Cancer in a Racially/Ethnically Diverse Population of Mainly Women Who Do Not Drink Alcohol: The MEC Study.
    Gram IT; Park SY; Kolonel LN; Maskarinec G; Wilkens LR; Henderson BE; Le Marchand L
    Am J Epidemiol; 2015 Dec; 182(11):917-25. PubMed ID: 26493265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Obesity and Type 2 Diabetes with Non-Hodgkin Lymphoma: The Multiethnic Cohort.
    Maskarinec G; Brown SM; Lee J; Bogumil D; Walsh C; Haiman CA; Setiawan VW; Shvetsov YB; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1348-1355. PubMed ID: 37555836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and non-Hodgkin lymphoma survival in an ethnically diverse population: the Multiethnic Cohort study.
    Leo QJ; Ollberding NJ; Wilkens LR; Kolonel LN; Henderson BE; Le Marchand L; Maskarinec G
    Cancer Causes Control; 2014 Nov; 25(11):1449-59. PubMed ID: 25070667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between diabetes medication use and risk of second breast cancer events and mortality.
    Calip GS; Yu O; Hoskins KF; Boudreau DM
    Cancer Causes Control; 2015 Aug; 26(8):1065-77. PubMed ID: 25956271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type II Diabetes, Obesity, and Breast Cancer Risk: The Multiethnic Cohort.
    Maskarinec G; Jacobs S; Park SY; Haiman CA; Setiawan VW; Wilkens LR; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2017 Jun; 26(6):854-861. PubMed ID: 28087607
    [No Abstract]   [Full Text] [Related]  

  • 14. Interethnic Differences in Bladder Cancer Incidence and the Association between Type 2 Diabetes and Bladder Cancer in the Multiethnic Cohort Study.
    Bogumil D; Cortessis VK; Wilkens LR; Le Marchand L; Haiman CA; Maskarinec G; Setiawan VW
    Cancer Res Commun; 2023 May; 3(5):755-762. PubMed ID: 37377897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study.
    Hosio M; Urpilainen E; Hautakoski A; Marttila M; Arffman M; Sund R; Ahtikoski A; Puistola U; Karihtala P; Jukkola A; Läärä E
    Acta Oncol; 2020 Sep; 59(9):1110-1117. PubMed ID: 32478629
    [No Abstract]   [Full Text] [Related]  

  • 16. Metformin and other anti-diabetic medication use and breast cancer incidence in the Nurses' Health Studies.
    Wang T; Chai B; Chen WY; Holmes MD; Erdrich J; Hu FB; Rosner BA; Tamimi RM; Willett WC; Kang JH; Eliassen AH
    Int J Cancer; 2024 Jul; 155(2):211-225. PubMed ID: 38520039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 Diabetes and all-cause mortality among Spanish women with breast cancer.
    Fernández-Arce L; Robles-Rodríguez N; Fernández-Feito A; Llaneza-Folgueras A; Encinas-Muñiz AI; Lana A
    Cancer Causes Control; 2022 Feb; 33(2):271-278. PubMed ID: 34853980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Type 2 Diabetes in the Multiethnic Cohort.
    Maskarinec G; Kristal BS; Wilkens LR; Quintal G; Bogumil D; Setiawan VW; Le Marchand L
    Can J Diabetes; 2023 Dec; 47(8):627-635.e2. PubMed ID: 37406880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer extent and survival among diabetic women in a Finnish nationwide cohort study.
    Murto MO; Artama M; Pukkala E; Visvanathan K; Murtola TJ
    Int J Cancer; 2018 Jun; 142(11):2227-2233. PubMed ID: 29318620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary isoflavone intake and all-cause mortality in breast cancer survivors: The Breast Cancer Family Registry.
    Zhang FF; Haslam DE; Terry MB; Knight JA; Andrulis IL; Daly MB; Buys SS; John EM
    Cancer; 2017 Jun; 123(11):2070-2079. PubMed ID: 28263368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.